CRO Services
As a trusted partner in clinical research, ProPharma brings 20+ years of expertise, seamlessly integrating with your team to turn scientific breakthroughs into life-changing therapies.
Customizable, Scalable, Strategy-Led, Global Contract Research Organization Services
ProPharma stands at the forefront of the contract research organization industry, offering a comprehensive suite of services that span the entire drug, device and diagnostics development lifecycle. As a full-service CRO, ProPharma excels in providing end-to-end solutions, from early research to post-marketing surveillance. Our expertise encompasses Phase I-IV clinical research, regulatory sciences, pharmacovigilance, and quality assurance, ensuring that each project meets the highest standards of quality and compliance.
CRO Services
Our clinical research experts offer solutions to bring your product to market, regardless of where you are in your product’s lifecycle.
Clinical Research Solutions
Full-Service CRO
The path to project success begins with choosing the right model and methodology to anticipate and manage the challenges that could arise during the lifecycle of a clinical trial. In response to more stringent regulations, globalization, and ever-changing technologies, ProPharma can build and tailor the optimal operational model to support consistent quality delivery and maximize participant recruitment and retention while expanding access to diverse populations. We will work with you to develop strategic, flexible approaches that leverage technology, clinical informatics, and our global reach to maximize data‑driven decision making that drives safety, quality, and efficiency.
Clinical Operations Services
Clinical operations play a pivotal role in the successful execution of clinical research, encompassing the design, implementation, and management of Phase I to IV trials.
With the increasing complexity of clinical trials, driven by heightened regulatory guidelines, the pressure on clinical operations teams has intensified. While some organizations allocate considerable time and resources to this aspect, others opt to outsource their clinical trials to Contract Research Organizations (CROs) specializing in the specific field of research. These CROs offer comprehensive services, ensuring end-to-end support for the seamless execution of trials.
Our dedicated clinical operations team collaborates with you to optimize the design of your clinical trials, implement patient-centric approaches, and provide guidance throughout the entire clinical development lifecycle. Discover how our experts can assist you in the multi-phase development of your clinical operations.

Global Clinical Trial Management Teams
Global footprint, local expertise: we provide the flexibility you need in a rapidly evolving environment. Our experienced teams offer the footprint to meet your local clinical trial needs, with the confidence and agility to globalize when you are ready. Our global governance structure streamlines the complexity of multi-region studies.
Data Safety Monitoring Board
Data Safety Monitoring Board (DSMB) services provide you with improved workflows, compliance, and communication to ensure the safety and integrity of your clinical study data.
PhoPharma’s team of medical consultants provide the option of safety data review (i.e., individual case safety reports and/or aggregate summaries of data) by a physician with experience in pharmacovigilance. The review and consultation include an assessment of the data and its significance to the conduct of the study. Our team then provides a recommendation for any actions to be taken, including reporting of aggregate data to the FDA as an IND Safety Report, requesting review by the DSMB, and/or changes to the Investigator's Brochure, Informed Consent Form, or study protocol.
ProPharma's DSMB, medical monitoring, and physician teams support a wide variety of therapeutic areas and will meet your requirements and keep your study moving forward by providing any or all of the following services:
- DSMB program support
- Blinded and unblinded DSMB meeting support
- Eligibility requirements review for inclusion/exclusion criteria issues
- Protocol review for exemptions and deviations
- Medical crisis impact review involving a study patient
- Biostatistician review
- Laboratory findings review
- Reporting a serious adverse event (SAE)
- Causality assessment discussions
- Clinical Trial Emergency Unblinding Services
Medical Monitoring Services
At ProPharma, our medical monitoring consultants will work with you to ensure safety and compliance throughout your clinical trials, from pre-trial planning through end-of-trial review.
Our team of physicians can evaluate your medical monitoring system to ensure there are no pharmacovigilance medical monitoring bandwidth issues, and partner with you to ensure you have the right resources to keep your clinical trials on schedule.
We will help you meet requirements to maintain quality and compliance throughout your clinical trials. Our medical monitors have vast knowledge in a wide variety of therapeutic areas and partner with you to address all your needs, including:
- Inclusion/exclusion criteria issues
- Protocol exemptions and deviations
- Medical crisis monitoring for cases involving a study patient
- Medication issues
- Laboratory findings
- SAE reporting
- Causality assessment discussions
Contact us to learn more about our medical monitoring services and how we can provide expert guidance for your upcoming clinical trials.
Clinical Trials for Pharmaceuticals, Biologics, Medical Devices, and Diagnostics
With dedicated pharmaceutical, medical device, and diagnostics teams, ProPharma supports clinical trials in the most cutting-edge technologies, maintaining expertise in novel uses of less novel therapeutics, and repurposing products. We have internal SMEs including a Biologics Center of Excellence and create solutions to complex challenges.
Expertise Across All Study Phases and Therapeutic Areas / Specialties
Our teams work together to take you all the way through the development lifespan, from early pilot studies dose-ranging studies through pivotal registration studies. We focus on the patients, providing consistent delivery of the quality data you need.

Deep Functional Expertise
ProPharma’s Medical Writing teams create best-in-class quality documents to support all elements of your clinical trial needs, from protocol and consent forms, Investigator’s Brochures, clinical study reports, patient narratives, and CTD Module documents, to registering and disclosing clinical trial information on public registries and redacting documents to meet commercial transparency obligations while protecting patient and company confidentiality.
Our world-class Biostatistics and Data Management teams and programmers are adept at creating and managing quality design, build, and outputs. They will partner with you to ensure you achieve the most robust and successful outcomes, incorporating unique and adaptive designs where best suited.
Global pharmacovigilance specialists and medical monitors are here to support the safe implementation of your studies, and provide expert guidance, reporting, and DSMB management. We have a range of disease and therapy area experts to ensure you have the best, contemporary advice.
Site & Patient Services
ProPharma's Site & Patient Services act as a seamless extension of the site team, combining experienced staff, standardized processes, and enabling technology to deliver consistent, compliant support worldwide. This integrated approach accelerates start-up, speeds enrollment, improves retention, streamlines visits, and enhances the patient experience across traditional, hybrid, and decentralized clinical trials (DCTs).
By unifying site, patient, and operational support into one coordinated model, we reduce the administrative and logistical burdens that commonly slow studies. Our teams adapt to each protocol and region, support high‑impact activities such as pre‑screening, patient outreach, and home health visits, and ensure sites have the resources they need at every stage. This flexible framework helps sponsors improve efficiency, strengthen participant engagement, and maintain quality across any study design or trial setting.
Site Support
Our flexible resourcing and patient centric support solutions empower clinical sites with both onsite and remote staffing options tailored to the unique needs of each study. We provide highly qualified professionals – including Study Coordinators, Research Assistants, and specialized roles such as Dieticians, Data Managers, and more – allowing sites to expand capacity by supplementing existing teams with the right expertise at the right time. Through customized support models designed for traditional, hybrid, decentralized (DCT), and fully virtual clinical trials, we enhance patient centricity by improving engagement, compliance, and retention.
Backed by ProPharma’s global network of clinical research professionals, our scalable approach ensures sites receive reliable, high quality support that strengthens operational efficiency and elevates the overall patient and site experience. Our team can support your sites at every step of the study process starting from patient recruitment and pre-screening to data entry and visit reminders, we help sites stay focused on what counts – delivering exceptional patient care and driving study success.
Home Visits
It can be overwhelming to determine how to deploy a patient-centric approach, so incorporating home visits into your protocol is often a great place to start. ProPharma can support home visits as part of a hybrid or fully virtual trial design. Home visits allow for greater flexibility in your study design and reduce the burden of participation by creating processes that fit into the patient’s life, rather than asking the patient to fit their life into the trial. Allowing simple procedures to be performed in the patient’s home also reduces the burden on the site by enabling site staff to focus on recruiting, enrolling patients, and managing more complex procedures.
Home Visits
It can be overwhelming to determine how to deploy a patient-centric approach, so incorporating home visits into your protocol is often a great place to start. ProPharma can support home visits as part of a hybrid or fully virtual trial design. Home visits allow for greater flexibility in your study design and reduce the burden of participation by creating processes that fit into the patient’s life, rather than asking the patient to fit their life into the trial. Allowing simple procedures to be performed in the patient’s home also reduces the burden on the site by enabling site staff to focus on recruiting, enrolling patients, and managing more complex procedures.
Home Visit Procedures
Our visit capabilities include critical procedures that support your clinical trial’s success. Let our team of experts review your protocol or draft synopsis and consult with your team on which visits or study activities could benefit from a Site & Patient Services model. Our procedural capabilities are as follows:
- Vital Signs and Associated Variables
- Temperature
- Respirations
- Blood Pressure
- Pulse/Pulse Oximetry
- Weight/Height/BMI
- Lab Sample Collection and Processing
- Blood/Plasma
- Urine
- Saliva/Sputum
- Stool
- Finger Sticks
- IP Logistics
- Targeted Clinical Assessments
- IP Administration
- Infusion
- Injection
- Oral
- Topical
- Telehealth Support
- Patient-Reported Outcomes and Scales
- Patient Training
- IP Administration
- Diary Completion
- Device or Wearables
- Other Safety Assessments
- Changes in Health Status or Concomitant Medications
- ECG Collection
Streamlined Technology
Our comprehensive clinical research platform integrates a robust Clinical Trial Management System (CTMS) designed for seamless site activity tracking, ensuring real-time visibility into study progress and operational performance. With built-in eSource, eConsent, and Telehealth capabilities, the platform fully supports remote and hybrid clinical trials, enabling participants and site support staff to engage virtually while maintaining data integrity and regulatory compliance. By streamlining workflows and automating routine tasks, the solution significantly reduces administrative burden for both sites and sponsors—ultimately enhancing efficiency, improving patient experience, and empowering research teams to focus on high-value clinical activities.
Embedded Solutions
Our team of project leaders and clinical subject matter practitioners can support you in your journey to successfully deliver projects, achieve critical outcomes, and realize or improve efficiencies. Whether you are looking for an expert to provide advisory services or several cross-disciplinary personnel our solutions-focused approach will add value to your organization.
In-Depth Expertise
Our team of clinical experts bring leadership to your projects to help you successfully complete your important, complex projects regardless of where your team is in the clinical development process. We help you get to decisions quickly and achieve outcomes.
Global Medical Writing Transparency
ProPharma strategically partners with clients to provide individualized, single-source, scalable medical writing solutions across the following areas:
- Medical Writing – Clinical, Nonclinical, Device, Diagnostics, and Publications
- Quality Control Review and Editing
- Clinical Trials Disclosure – Document Redaction/Anonymization, Clinical Trial Registry Authoring, Plain Language Authoring, and Management Consultation
- Project Support – Project Management, Document Publishing, Submission Management, SOP Development/Template Creation
Our global team of medical writers and reviewers have deep domain expertise and autonomously drive projects to completion, collaborating with cross-functional teams to coordinate all aspects of input, production, and review of every document with a laser focus on quality. Whether you need to outsource all medical writing across several clinical trials or a portfolio of products, or you need project-based support for individual medical writing deliverables, our expertise and experience can be leveraged to build a customized solution that achieves all your project goals.
CRO Experts
-
Vicki Gashwiler
Global Head, Clinical Operations
-
Helen Hall
Global Head, Clinical Data Sciences
-
Shelby Stillwagon
Vice President, Decentralized Clinical Trials
Vicki Gashwiler
Vicki Gashwiler serves as the global head of MedTech , managing a global team of device quality, regulatory, and clinical professionals. Vicki has 20+ years of medical device development experience and a background in healthcare as a Registered Nurse. Her experience includes global regulatory oversight, clinical operations management (including clinical monitoring, clinical trial management, and project management), clinical quality management, and QMS oversight. After working as a critical care and cardiac nurse, she began her industry career at Abbott Vascular, expanding her experience at multiple-sized CROs and at a start-up pharmaceutical company. These roles have prepared her to support medical device companies with devices in the start-up / concept phase through post-market, globally marketed products.
Helen Hall
Shelby Stillwagon
News & Insights
June 1, 2026
Why Medical Information Is Critical to Adverse Event Reporting
Discover the vital role of Medical Information in adverse event reporting and how it enhances patient safety and regulatory compliance in the pharmaceutical industry.
May 25, 2026
Rethinking the Role of the Medical Information Contact Center: An Untapped Resou...
Explore how Medical Information contact centers can enhance medical writing by leveraging their expertise and adaptability in response to evolving demands.
May 27, 2026
ProPharma Appoints Adrian Pencak as Chief Commercial Officer
ProPharma announces Adrian Pencak as Chief Commercial Officer, bringing 25 years of leadership experience to enhance global commercial capabilities and client partnerships.
January 27, 2026
ProPharma Sets the Gold Standard in Sustainability with SBTi-Approved Net-Zero T...
ProPharma’s greenhouse gas reduction targets are validated by SBTi, aligning with the Net-Zero Standard and a commitment to reach net-zero by 2050.
January 31, 2025
ProPharma Recognized for AI Excellence at ECCCSA
ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.
October 9, 2024
ProPharma Receives 2024 CPHI Regulatory and Compliance Award
ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.
May 20, 2026
Keeping Research Moving Under Pressure: Delivering Data Integrity at Speed - Pro...
When patient enrollment rapidly exceeds expectations, clinical trials can face significant operational strain, putting data integrity, timelines, and critical sponsor decisions at risk. A mid-size...
May 20, 2026
From Clinical Hold to Approval: Overcoming CMC Challenges to Achieve BLA Approva...
A critical CMC change during Phase 3 development led to a partial clinical hold, putting timelines, regulatory alignment, and commercial readiness at risk. In this case study, learn how we partnered...
May 15, 2026
Response to Regulatory Request with Subsequent Full Signal Assessment - ProPharm...
Responding to urgent regulatory safety requests requires balancing speed, scientific rigor, and global compliance. When concerns emerged regarding a potential neurotoxicity signal, the client needed...
June 2, 2026
Foundations of a Compliant EU–UK GMP–GDP Supply Chain: From Importation to Distribution
A compliant and efficient EU–UK GMP–GDP supply chain requires a clear understanding of roles, responsibilities, and operational integration across importation, certification, and distribution...
April 23, 2026
Clinical Promise to Commercial Reality: The Path to Cell & Gene Therapy Market
As cell and gene therapies transition from clinical development to commercialization, organizations face evolving regulatory expectations, expanded CMC requirements, and increased MAH...
April 9, 2026
EMA Policy 0070: Advanced Strategies for Compliance, Anonymization, and CCI Justification
As European Medicines Agency Policy 0070 enters its expanded Step 2 phase, sponsors face increased document volumes, heightened transparency obligations, and greater scrutiny of anonymization and CCI...
News & Insights
May 20, 2026
Keeping Research Moving Under Pressure: Delivering Data Integrity at Speed - Pro...
When patient enrollment rapidly exceeds expectations, clinical trials can face significant operational strain, putting data integrity, timelines, and critical sponsor decisions at risk. A mid-size...
May 20, 2026
From Clinical Hold to Approval: Overcoming CMC Challenges to Achieve BLA Approva...
A critical CMC change during Phase 3 development led to a partial clinical hold, putting timelines, regulatory alignment, and commercial readiness at risk. In this case study, learn how we partnered...
May 15, 2026
Response to Regulatory Request with Subsequent Full Signal Assessment - ProPharm...
Responding to urgent regulatory safety requests requires balancing speed, scientific rigor, and global compliance. When concerns emerged regarding a potential neurotoxicity signal, the client needed...
April 9, 2026
EMA Policy 0070: Advanced Strategies for Compliance, Anonymization, and CCI Justification
As European Medicines Agency Policy 0070 enters its expanded Step 2 phase, sponsors face increased document volumes, heightened transparency obligations, and greater scrutiny of anonymization and CCI...
Complex Needs Require Custom Solutions
ProPharma builds solutions at the intersection of innovation and flexibility. We’re here to offer a custom alternative that fits your unique needs. Standout solutions scaled to your size.